Broad spectrum of neuropsychiatric phenotypes associated with white matter disease in PTEN hamartoma tumor syndrome.
Tuğçe B BalcıJorge DavilaDenice LewisAddo BoafoErick SellJulie RicherSarah M NikkelChristine M ArmourEva TomiakMatthew A LinesSarah L SawyerPublished in: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics (2017)
White matter lesions have been described in patients with PTEN hamartoma tumor syndrome (PHTS). How these lesions correlate with the neurocognitive features associated with PTEN mutations, such as autism spectrum disorder (ASD) or developmental delay, has not been well established. We report nine patients with PTEN mutations and white matter changes on brain magnetic resonance imaging (MRI), eight of whom were referred for reasons other than developmental delay or ASD. Their clinical presentations ranged from asymptomatic macrocephaly with normal development/intellect, to obsessive compulsive disorder, and debilitating neurological disease. To our knowledge, this report constitutes the first detailed description of PTEN-related white matter changes in adult patients and in children with normal development and intelligence. We present a detailed assessment of the neuropsychological phenotype of our patients and discuss the relationship between the wide array of neuropsychiatric features and observed white matter findings in the context of these individuals.
Keyphrases
- white matter
- autism spectrum disorder
- pi k akt
- multiple sclerosis
- cell proliferation
- magnetic resonance imaging
- obsessive compulsive disorder
- end stage renal disease
- attention deficit hyperactivity disorder
- chronic kidney disease
- signaling pathway
- computed tomography
- young adults
- contrast enhanced
- newly diagnosed
- healthcare
- case report
- prognostic factors
- high resolution
- peritoneal dialysis
- high throughput
- deep brain stimulation
- mild cognitive impairment
- mass spectrometry
- patient reported outcomes
- single cell